Erythropoietin (EPO) is a 30.4 kD glycoprotein that is the major growth factor regulating the production of circulating erythrocytes. EPO acts by binding to receptors on the surface of the erythroid progenitor cells in the bone marrow and other hematopoietic tissues, leading to an increase in survival, proliferation, and differentiation of erythroid progenitor cells, which ultimately results in increase in reticulocytes (RET), red blood cell (RBC) and hemoglobin concentrations. Recombinant human EPO (rHuEPO) has been approved for the treatment of anemia associated with renal failure, cancer chemotherapy, and the treatment of acquired immunodeficiency syndrome. The total maturation time of erythroblasts and reticulocytes is of the order of 4 days, of which 3 days are spent in bone marrow and 1 day in the peripheral circulation. A single intravenous bolus administration of rHuEPO into healthy subjects results in an immediate release to the circulation of the immature reticulocytes, followed by a 1.5 day delayed release of reticulocytes arising from the stimulation of erythropoiesis by rHuEPO [1]. This indicates that in addition to an increase in the number of reticulocyte precursors, rHuEPO shortens their transit time from early erythrobrasts to reticulocytes in the bone marrow. Another consequence of rHuEPO is a transient change in the age distribution of circulating reticulocytes. The maturation time of about 1 day for homeostatic reticulocytes in the circulation extends to about 3 days for stress reticulocytes [1]. This phenomenon has been confirmed by other investigators for phlebotomy-induced stress erythropoiesis [2]. Recently, it has been demonstrated in healthy subjects that the maturation time in the circulation for stress reticulocytes depends on rHuEPO dose [3].
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• rHuEPO both stimulates the production of the marrow progenitor cells and transiently increases the mean transition time of the circulating reticulocytes.
• Both effects contribute to the increase in the reticulocyte counts in a dose-dependent manner.
• The change in the reticulocyte maturation time cannot be solely explained by the release to the circulation of the stress immature reticulocytes.
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Reticulocyte residence time distribution. The jth reticulocyte compartment Rj can be considered as a subpopulation of reticulocytes of the mean residence time in the circulation aj calculated as the sum of the mean residence times for compartments R 1 , …, R j : aj(t) = j⋅MRT(t) , where both aj and MRT (k = 1,…,j) are time dependent, since the first-order transfer rates between the reticulocyte pools were dependent on the transduction signal. For this model, and for time t = t 0 , MRT(t 0 ) were calculated as follows At a time t = t 0 , the probability density function (p.d.f.) of the reticulocyte age distribution and the mean reticulocyte residence time were determined as follows:
Software. Nonlinear mixed effects modeling was performed using NONMEM® V level 1.1 (GloboMax, Hanover, MD, USA). Non-parametric bootstrap analysis was performed using the package Wings for NONMEM (N. Holford, Version 4.04, June 2003, Auckland, New Zealand). (panel A and B) and PD model (panels C and D) . 
